FDA Inspection 767080 — B & G Labs, Inc

B & G Labs, Inc — FEI 1943943

The FDA completed an inspection of B & G Labs, Inc on February 10, 2012 in Saint Louis, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 19 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 10, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Saint Louis, MO (United States)

Citations

IDCFRDescription
113421 CFR 211.25(b)Supervisor Training/Education/Experience
115921 CFR 211.28(a)Clothing appropriate for duties performed
116421 CFR 211.28(c)Unauthorized Personnel in Limited Access Areas
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
122721 CFR 211.67(c)Cleaning/maintenance records not kept
136121 CFR 211.100(a)Absence of Written Procedures
139321 CFR 211.103Yield calculations not verified by 2nd person
183321 CFR 211.84(d)(1)Identity Testing of Each Component
188321 CFR 211.165(a)Testing and release for distribution
188521 CFR 211.165(b)Microbiological testing
191221 CFR 211.166(a)Written program not followed
200921 CFR 211.188Prepared for each batch, include complete information
355721 CFR 211.52Washing and toilet facilities are deficient
355921 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
356221 CFR 211.56(c)Written procedures lacking for use of pesticides etc.
356521 CFR 211.58Buildings not maintained in good state of repair
360321 CFR 211.160(b)Scientifically sound laboratory controls
431421 CFR 211.84(d)(2)Reports of Analysis (Components)
437621 CFR 211.188(b)(4)Weights and measures of components used